Insulin secretion in patients with chronic hepatitis treated with lipostabil.
In 12 patients with chronic hepatitis the carbohydrate tolerance and insulin secretion after intravenous and oral glucose loading were determined before and after lipostabil treatment. A significant rise of fasting insulinemia and hypersecretion of insulin after intravenous glucose loading were observed. After oral glucose loading the rise of insulinemia was significantly lower in patients than in healthy controls, despite a greater increase in glycemia. Administration of lipostabil for 2 weeks failed to exert any significant effect on carbohydrate intolerance and disturbances in insulin secretion, which were present in patients with chronic hepatitis.
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002908:Chronic Disease; D005260:Female; D006505:Hepatitis / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D010713:Phosphatidylcholines; C005152:lipostabil